APA (7th ed.) Citation

O, N., C, O., D, M., N, L., S, F. M., PE, P. V., . . . S, M. (2025). Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: A population-based case-control study, Spain, 2023/24 season. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 30(5), . https://doi.org/10.2807/1560-7917.ES.2025.30.5.2400596

Chicago Style (17th ed.) Citation

O, Núñez, et al. "Effectiveness of Catch-up and At-birth Nirsevimab Immunisation Against RSV Hospital Admission in the First Year of Life: A Population-based Case-control Study, Spain, 2023/24 Season." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 30, no. 5 (2025). https://doi.org/10.2807/1560-7917.ES.2025.30.5.2400596.

MLA (9th ed.) Citation

O, Núñez, et al. "Effectiveness of Catch-up and At-birth Nirsevimab Immunisation Against RSV Hospital Admission in the First Year of Life: A Population-based Case-control Study, Spain, 2023/24 Season." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 30, no. 5, 2025, https://doi.org/10.2807/1560-7917.ES.2025.30.5.2400596.